![Jinsheng Ren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jinsheng Ren
Vorstandsvorsitzender bei
SIMCERE PHARMACEUTICAL GROUP LIMITED
Vermögen: 346 Mio $ am 31.08.2026
Profil
Jinsheng Ren is the founder of Simcere Pharmaceutical Group Ltd., founded in 1995, serving as Chairman & Chief Executive Officer.
Mr. Ren is the founder of Jiangsu Simcere Pharmaceutical Co., Ltd., founded in 1995, serving as Chairman & Chief Executive Officer.
Current jobs include Chairman at Simcere Pharmaceutical (Hainan) Co. Ltd. since 2001, Vice Chairman at Iangsu Association for Science & Technology, Chairman at Shandong Simcere Biopharmaceutical Co. Ltd. since 2009, Chairman at Simcere Pharmaceutical Co., Ltd. since 2003, Non-Executive Director at Simcere Zaiming Pharmaceutical Co. Ltd. since 2025, and Vice President at China Pharmaceutical Innovation & Research Development Assoc.
Former jobs include Director at Chongqing Hifuture Information Technology Co., Ltd., Departamental Manager at Jiangsu Pharmaceutical Industries Co., Ltd. in 1995, and Vice General Manager at Qidong Gaitianli Medicines Co., Ltd. in 1992.
Education includes graduate degrees from Macquarie University in 2003 and Nanjing Normal University in 1996, and an undergraduate degree from Nanjing University of Traditional Chinese Medicine in 1982.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.07.2026 | 244’586’948 ( 9.52% ) | 346 Mio $ | 31.08.2026 |
Aktive Positionen von Jinsheng Ren
| Unternehmen | Position | Beginn |
|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Vorstandsvorsitzender | 20.08.2026 |
Simcere Pharmaceutical (Hainan) Co. Ltd.
 Simcere Pharmaceutical (Hainan) Co. Ltd. Pharmaceuticals: OtherHealth Technology Engages in pharmaceuticals production | Vorsitzender | 21.06.2011 |
China Pharmaceutical Innovation & Research Development Assoc | Corporate Officer/Principal | - |
Iangsu Association for Science & Technology | Direktor/Vorstandsmitglied | - |
Jiangsu Simcere Pharmaceutical Co., Ltd.
 Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Vorstandsvorsitzender | 01.03.1995 |
Simcere Pharmaceutical Co. Ltd.
 Simcere Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | 01.02.2003 |
Shandong Simcere Biopharmaceutical Co. Ltd. | Vorsitzender | 01.07.2009 |
Ehemalige bekannte Positionen von Jinsheng Ren
| Unternehmen | Position | Ende |
|---|---|---|
Jiangsu Pharmaceutical Industries Co., Ltd. | Corporate Officer/Principal | 01.01.1995 |
Qidong Gaitianli Medicines Co., Ltd.
 Qidong Gaitianli Medicines Co., Ltd. Qidong Gaitianli Medicines Co., Ltd. is a modern pharmaceutical company specializing in the research, development, manufacturing, and sales of traditional Chinese medicine (TCM) solid preparations. Qidong Gaitianli conducts clinical research on the efficacy and safety of its products in cancer and kidney diseases and provides information on its website about its operations and products. The company is based in Qidong, China. The Chinese company produces core products such as Huaier granules, derived from Trametes robiniophila murr, used as adjunctive therapy for various cancers, and Huaiqihuang granules, which combine huai ’ er fungus, goji berry, and polygonatum for immune modulation and treatment of immune-related diseases. | Corporate Officer/Principal | 01.01.1992 |
| ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Jinsheng Ren
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Simcere Pharmaceutical Group Ltd.
 Simcere Pharmaceutical Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded generic drugs | Health Technology |
Macquarie University
 Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Simcere Pharmaceutical (Hainan) Co. Ltd.
Simcere Pharmaceutical (Hainan) Co. Ltd. Pharmaceuticals: OtherHealth Technology Engages in pharmaceuticals production | Health Technology |
Chongqing Hifuture Information Technology Co., Ltd.
 Chongqing Hifuture Information Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops develops and manufactures pharmaceuticals & operates electric charging stations, electrical equipment and gaming platform | Health Technology |
Nanjing Normal University
 Nanjing Normal University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University of Traditional Chinese Medicine
 Nanjing University of Traditional Chinese Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Pharmaceutical Industries Co., Ltd. | |
Qidong Gaitianli Medicines Co., Ltd.
Qidong Gaitianli Medicines Co., Ltd. Qidong Gaitianli Medicines Co., Ltd. is a modern pharmaceutical company specializing in the research, development, manufacturing, and sales of traditional Chinese medicine (TCM) solid preparations. Qidong Gaitianli conducts clinical research on the efficacy and safety of its products in cancer and kidney diseases and provides information on its website about its operations and products. The company is based in Qidong, China. The Chinese company produces core products such as Huaier granules, derived from Trametes robiniophila murr, used as adjunctive therapy for various cancers, and Huaiqihuang granules, which combine huai ’ er fungus, goji berry, and polygonatum for immune modulation and treatment of immune-related diseases. | |
China Pharmaceutical Innovation & Research Development Assoc | |
Iangsu Association for Science & Technology | |
Simcere Pharmaceutical Co. Ltd.
Simcere Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Shandong Simcere Biopharmaceutical Co. Ltd. |
